Patents by Inventor Liv Thomsen

Liv Thomsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis Of Benzodiazepine Derivatives
    Publication number: 20230055040
    Abstract: The invention relates to processes for the synthesis of benzodiazepine derivatives of Formula I: (I)
    Type: Application
    Filed: August 9, 2022
    Publication date: February 23, 2023
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Synthesis of benzodiazepine derivatives
    Patent number: 11447454
    Abstract: The invention relates to processes for the synthesis of benzodiazepine derivatives of Formula I:
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: September 20, 2022
    Assignee: TRIO MEDICINES LIMITED
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Benzodiazepine derivatives as CCK2/gastrin receptor antagonists
    Patent number: 10906884
    Abstract: The invention relates to benzodiazepine derivatives of formula (A) useful as CCK2/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK2/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: February 2, 2021
    Assignee: TRIO MEDICINES LTD
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Synthesis Of Benzodiazepine Derivatives
    Publication number: 20200223807
    Abstract: The invention relates to processes for the synthesis of benzodiazepine derivatives of Formula I:
    Type: Application
    Filed: January 13, 2020
    Publication date: July 16, 2020
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Synthesis of benzodiazepine derivatives
    Patent number: 10570102
    Abstract: The invention relates to processes for the synthesis of benzodiazepine derivatives of Formula I: (I)
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: February 25, 2020
    Assignee: TRIO MEDICINES LIMITED
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Benzodiazepine Derivatives As CCK2/Gastrin Receptor Antagonists
    Publication number: 20190233391
    Abstract: The invention relates to benzodiazepine derivatives of formula (A) useful as CCK2/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK2/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.
    Type: Application
    Filed: April 12, 2019
    Publication date: August 1, 2019
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Benzodiazepine derivatives as CCK2/gastrin receptor antagonists
    Patent number: 10308627
    Abstract: The invention relates to benzodiazepine derivatives of formula (A) useful as CCK2/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK2/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: June 4, 2019
    Assignee: TRIO MEDICINES LTD
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Synthesis Of Benzodiazepine Derivatives
    Publication number: 20180237400
    Abstract: The invention relates to processes for the synthesis of benzodiazepine derivatives of Formula I: (I)
    Type: Application
    Filed: August 5, 2016
    Publication date: August 23, 2018
    Inventors: Malcom James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood
  • Benzodiazepine Derivatives As CCK2/Gastrin Receptor Antagonists
    Publication number: 20180215728
    Abstract: The invention relates to benzodiazepine derivatives of formula (A) useful as CCK2/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK2/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.
    Type: Application
    Filed: August 7, 2015
    Publication date: August 2, 2018
    Inventors: Malcolm James Boyce, Liv Thomsen, Donald Alan Gilbert, David Wood